Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ: PODD )

259.38 +12.89 (+5.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Insulet Publishes 2022 Sustainability Report Focused on Innovating for the Future and Preserving the Environment
From Insulet Corporation
Via Business Wire
Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes
From Insulet Corporation
Via Business Wire
4 Analysts Have This to Say About Insulet
Via Benzinga
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
Medical stocks are holding up amid economic and market uncertainty. 
Via Investor's Business Daily
Analyst Expectations for Insulet's Future
Via Benzinga
Preview: Insulet's Earnings
Via Benzinga
2 Best Medical Device Stocks for 2023
Insulet and Conmed ought to be medtech's shining stars in 2023. 
Via The Motley Fool
Insulet to Announce First Quarter 2023 Financial Results on May 4, 2023
From Insulet Corporation
Via Business Wire
CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (24% constant currency)
From Insulet Corporation
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Highly Anticipated Omnipod® 5 Real-World Evidence to be Presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
From Insulet Corporation
Via Business Wire
Looking Into Insulet's Return On Invested Capital
Via Benzinga
Earnings Scheduled For February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. 
Via Benzinga
3 Growth Stocks That Have Delivered 10X Returns Over the Past Decade
Are these stocks still good buys today? 
Via The Motley Fool
Insulet Acquires Assets of Automated Glucose Control LLC (AGC)
From Insulet Corporation
Via Business Wire
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies
From Insulet Corporation
Via Business Wire
The 7 Best Tech Stocks to Buy for February 2023
Some of the best tech stocks are looking increasingly attractive as the worst fears fail to materialize. Here are seven to consider. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
Via Benzinga
Insulet Has Potential To Gain More Than Analysts Are Forecasting
Even as it pulled back with the broader market Tuesday, insulin pump maker Insulet found support along its 50-day line and remained in possible buy range. 
Via MarketBeat
Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
From Insulet Corporation
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Dow Jones Giant UnitedHealth Among 5 Resilient Stocks In Sickly Market Rally
UnitedHealth is among medical stocks holding key support. 
Via Investor's Business Daily
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Insulet Issues Medical Device Correction For Omnipod 5 Controller Due To Faulty Charging
Via Benzinga
Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod® 5 Controller
From Insulet Corporation
Via Business Wire
Insulet Issued Voluntary Medical Device Correction for Omnipod DASH® Personal Diabetes Manager on October 17, 2022
From Insulet Corporation
Via Business Wire
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.